Recombinant human heparan N-sulfatase (rhHNS)
HGT-SAN-055
Phase 2 mab completed
Quick answer
Recombinant human heparan N-sulfatase (rhHNS) for Mucopolysaccharidosis (MPS) is a Phase 2 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Mucopolysaccharidosis (MPS)
- Phase
- Phase 2
- Modality
- mab
- Status
- completed